{"filing":{"accession_number":"0001097149-26-000065","cik":"0001097149","ticker":"ALGN","company_name":"ALIGN TECHNOLOGY INC","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-27","primary_document":"algn-20260827.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1097149/000109714926000065/algn-20260827.htm"},"events":[{"id":30595,"run_id":28046,"accession_number":"0001097149-26-000065","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The filing discloses the appointment of Quentin Blackford, an experienced healthcare executive (currently CEO of iRhythm Technologies), to Align Technology's Board of Directors effective August 27, 2026. While the section also mentions Andrea L. Saia's resignation, the principal disclosed action centers on the appointment of a new director. Blackford's appointment is material as it represents a change in board composition and governance at a large-cap medical device company, and his background in healthcare and digital innovation is relevant to investor assessment of board quality and strategic direction.","company_name":"ALIGN TECHNOLOGY INC","ticker":"ALGN","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":[{"id":33236,"accession_number":"0001097149-26-000065","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Quentin Blackford, an experienced healthcare executive (currently CEO of iRhythm Technologies), to Align Technology's Board of Directors effective August 27, 2026. While the section also mentions Andrea L. Saia's resignation, the principal disclosed action centers on the appointment of a new director. Blackford's appointment is material as it represents a change in board composition and governance at a large-cap medical device company, and his background in healthcare and digital innovation is relevant to investor assessment of board quality and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:11:45.945690+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33236,"accession_number":"0001097149-26-000065","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Quentin Blackford, an experienced healthcare executive (currently CEO of iRhythm Technologies), to Align Technology's Board of Directors effective August 27, 2026. While the section also mentions Andrea L. Saia's resignation, the principal disclosed action centers on the appointment of a new director. Blackford's appointment is material as it represents a change in board composition and governance at a large-cap medical device company, and his background in healthcare and digital innovation is relevant to investor assessment of board quality and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:11:45.945690+00:00","company_name":"ALIGN TECHNOLOGY INC","ticker":"ALGN","filing_date":"2026-08-31"}]}